circRNA basic information
circBase ID: hsa_circ_0060467
Name: hsa_circ_MYBL2
Synonym: circ0060467 / circ-0060467
Host Gene: MYBL2
Genomic location(hg19): -
Genomic location(hg38): -
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007256
MONDO name: hepatocellular carcinoma
Disease details: hepatocellular carcinoma / HCC
Disease DO ID:
684, 686
Disease MeSH ID:
D006528
Disease NCIt ID:
C3099
Disease ICD11 ID:
1294035808
Disease OMIM ID:
114550
Species: Human
Species details: Homo sapiens
Tissue specimen:

HCC tissues; matched normal tissues; xenograft tumors

Cell lines:

97H; BEL-7402; HepG2; LO2; 7402

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: AIFM2, GPX4, Ago2
Associated microRNA: miR-6085, miR-6805
Biological function: Promotes HCC progression and proliferation; inhibits ferroptosis.
Molecular mechanism: Acts as a ceRNA/miRNA sponge (miR-6805 and/or miR-6085), competing with AIFM2 and GPX4 for miRNA binding to increase AIFM2 and GPX4 expression and suppress ferroptosis.
Biological pathway or process:

proliferation (promotes); ferroptosis (inhibits); ceRNA regulation (promotes)

Detected method:
Q
M
Validation methods:

Microarray; RT-qPCR; RNase R Treatment; Actinomycin D / DRB Stability Assay; Transfection; CCK8; Transwell Assay; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Western Blot; In Vivo Animal Model; IHC (Immunohistochemistry); Clinical Sample Validation; Bioinformatics Analysis

Clinical significance:

May represent a novel diagnostic marker and therapeutic target for HCC.

Description:

circ0060467 is upregulated in HCC tissues and cell lines and promotes tumor growth. Mechanistically, it acts as a ceRNA/miRNA sponge to regulate AIFM2 and GPX4, thereby inhibiting ferroptosis and facilitating HCC progression. It is proposed as a potential diagnostic marker and therapeutic target for HCC.

Confidence score:

0.8432

Other information
Title:

Circ0060467 sponges miR-6805 to promote hepatocellular carcinoma progression through regulating AIFM2 and GPX4 expression.

Journal: Aging
Published: 2024
PubMed ID: 38244593
Study type:

combined biological and clinical study

Data availability: Authors can provide all of the datasets on reasonable request.
Code availability: -